121 related articles for article (PubMed ID: 6199431)
1. In vitro and in vivo activity profile of RHC 2851: a new orally effective antiallergic agent.
Khandwala A; Carlson R; Dally-Meade V; Donigi-Ruzza D
J Immunopharmacol; 1983; 5(4):311-32. PubMed ID: 6199431
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D
Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
[TBL] [Abstract][Full Text] [Related]
3. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. II. Comparison of RHC 3164 with disodium cromoglycate.
Khandwala A; Dally-Meade V; Jariwala N; Huang F
Int Arch Allergy Appl Immunol; 1984; 73(1):65-70. PubMed ID: 6198288
[TBL] [Abstract][Full Text] [Related]
4. RHC 3024: antiallergic activity in vitro and comparison with disodium cromoglycate and other antiallergic agents.
Khandwala A; Coutts SM; Dally-Meade V; Jariwala N; Huang FC
Int Arch Allergy Appl Immunol; 1983; 70(4):311-20. PubMed ID: 6186610
[TBL] [Abstract][Full Text] [Related]
5. Antiallergic activity profile in vitro of RHC 2963 and related compounds.
Khandwala A; Van Inwegen R; Coutts S; Dally-Meade V; Youssefyeh RD
Int J Immunopharmacol; 1983; 5(6):491-502. PubMed ID: 6198298
[TBL] [Abstract][Full Text] [Related]
6. Antiallergic activity of tiaramide (RHC 2592-A).
Khandwala A; Coutts S; Weinryb I
Int Arch Allergy Appl Immunol; 1982; 69(2):159-68. PubMed ID: 6179887
[TBL] [Abstract][Full Text] [Related]
7. RHC 3288 [1-methyl-2(1,3,4-oxadiazol-2(3H)-one-5-yl) benzimidazole] and related compounds. Novel inhibitors of histamine release from rat mast cells and human basophils.
Khandwala A; Coutts S; Dally-Meade V; Jariwala N; Musser J; Brown R; Jones H; Loev B; Weinryb I
Biochem Pharmacol; 1983 Nov; 32(22):3325-33. PubMed ID: 6197075
[TBL] [Abstract][Full Text] [Related]
8. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
Khandwala A; Coutts S; Pruss T; Jones H; Neiss E; Weinryb I
Biochem Pharmacol; 1987 Mar; 36(5):663-72. PubMed ID: 2435293
[TBL] [Abstract][Full Text] [Related]
9. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. I. A lack of correlation between inhibition of cyclic nucleotide phosphodiesterases and antigen-induced release of histamine from rat mast cells.
Khandwala A; Van Inwegen R; Coutts S; Dally-Meade V; Jariwala N; Huang F; Musser J; Brown R; Loev B; Weinryb I
Int Arch Allergy Appl Immunol; 1984; 73(1):56-64. PubMed ID: 6198287
[TBL] [Abstract][Full Text] [Related]
10. Antiallergic activity of nylidrin hydrochloride (RHC 3432-A). I. Effect on release of histamine in vitro from rat peritoneal mast cells, guinea pig lung slices and human basophils.
Khandwala A; Coutts SM; Weinryb I
Int Arch Allergy Appl Immunol; 1983; 70(4):295-302. PubMed ID: 6186608
[TBL] [Abstract][Full Text] [Related]
11. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models.
Singh R; Nath A; Gupta PP; Shukla M; Khare SK; Kundu B
Indian J Exp Biol; 2001 Sep; 39(9):871-7. PubMed ID: 11831367
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines.
Musser JH; Jones H; Sciortino S; Bailey K; Coutts SM; Khandwala A; Sonnino-Goldman P; Leibowitz M; Wolf P; Neiss ES
J Med Chem; 1985 Sep; 28(9):1255-9. PubMed ID: 2411926
[TBL] [Abstract][Full Text] [Related]
13. Effect of disodium cromoglycate on cutaneous basophil anaphylaxis.
Golden HW; Crean GL; Iacuzio DA; Otterness IG
J Immunol; 1986 Sep; 137(5):1495-503. PubMed ID: 2427571
[TBL] [Abstract][Full Text] [Related]
14. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
Nabe T; Yamamura H; Kohno S; Ohata K
Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
[TBL] [Abstract][Full Text] [Related]
15. Indolo[2,1-c][1,4]benzodiazepines: a new class of antiallergic agents.
Ho CY; Hageman WE; Persico FJ
J Med Chem; 1986 Jun; 29(6):1118-21. PubMed ID: 2872333
[TBL] [Abstract][Full Text] [Related]
16. Extracellular guanosine 3',5'-cyclic monophosphate and disodium cromoglycate share a similar spectrum of activity in the inhibition of histamine release from isolated mast cells and basophils.
Mackay GA; Pearce FL
Int Arch Allergy Immunol; 1996 Mar; 109(3):258-65. PubMed ID: 8620095
[TBL] [Abstract][Full Text] [Related]
17. Potent inhibitory activity of HSR-6071, a new antiallergic agent, on passive cutaneous anaphylaxis (PCA).
Makino E; Ohashi T; Takahashi H; Kato H; Ito Y; Nagai H; Koda A; Azuma H
Jpn J Pharmacol; 1990 Jan; 52(1):87-94. PubMed ID: 1689783
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological studies on oxatomide (KW-4354): (1) Effect on passive cutaneous anaphylaxis (PCA)].
Ohmori K; Ishii H; Hirayama T; Shuto K; Nakamizo N
Nihon Yakurigaku Zasshi; 1982 Sep; 80(3):251-60. PubMed ID: 6130032
[TBL] [Abstract][Full Text] [Related]
19. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 2-(2,3-dihydro-2-oxo-1,3,4-oxadiazol-5-yl) benzo heterocycles. A novel series of orally active antiallergic agents.
Musser JH; Brown RE; Loev B; Bailey K; Jones H; Kahen R; Huang FC; Khandwala A; Leibowitz M; Sonnino-Goldman P
J Med Chem; 1984 Feb; 27(2):121-5. PubMed ID: 6198518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
